These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 1966804

  • 1. PAF-agonistic and -antagonistic behaviour of new synthetic ether phospholipids. I. Studies on blood platelets in vitro.
    Ostermann G, Hofmann B, Kertscher HP, Till U.
    J Lipid Mediat; 1990; 2(1):21-31. PubMed ID: 1966804
    [Abstract] [Full Text] [Related]

  • 2. PAF-agonistic and -antagonistic behaviour of new synthetic ether phospholipids. II. Relationships between chemical structure and inhibition of PAF-induced human platelet activation.
    Ostermann G, Hofmann B, Kertscher HP, Till U.
    J Lipid Mediat; 1991; 3(2):225-37. PubMed ID: 1797154
    [Abstract] [Full Text] [Related]

  • 3. Platelet-stimulating and membranolytic properties of racemic PAF-acether and analogues.
    Ostermann G, Kertscher HP, Till U.
    Biomed Biochim Acta; 1985; 44(2):K17-23. PubMed ID: 4004829
    [Abstract] [Full Text] [Related]

  • 4. 1,4-Dihydropyridines, a new class of platelet-activating factor receptor antagonists: in vitro pharmacologic studies.
    Ortega MP, García MC, Gijón MA, de Casa-Juana MF, Priego JG, Sanchez Crespo M, Sunkel C.
    J Pharmacol Exp Ther; 1990 Oct; 255(1):28-33. PubMed ID: 2170624
    [Abstract] [Full Text] [Related]

  • 5. Structure-activity relationships for platelet-activating factor (PAF) and analogues reveal differences between PAF receptors on platelets and macrophages.
    Stewart AG, Grigoriadis G.
    J Lipid Mediat; 1991 Nov; 4(3):299-308. PubMed ID: 1662547
    [Abstract] [Full Text] [Related]

  • 6. [PAF-antagonists with a phospholipid structure. 1. Phospholipids with hetero-arene head groups: synthesis, characterization and determination of the action of structural elements].
    Kertscher HP, Ostermann G, Findeisen M, Limmer S, Gawrisch K.
    Pharmazie; 1991 Aug; 46(8):575-9. PubMed ID: 1798710
    [Abstract] [Full Text] [Related]

  • 7. Proaggregatory and inhibitory effects of 2-O-ethyl analogues of platelet-activating factor (PAF) on human and rabbit platelets.
    Hofmann B, Ostermann G, Kertscher HP, Till U.
    Thromb Res; 1988 Feb 15; 49(4):415-23. PubMed ID: 3381200
    [Abstract] [Full Text] [Related]

  • 8. Inhibitory effects of the novel platelet activating factor receptor antagonist, 1-ethyl-2-[N-(2-methoxy)benzoyl-N-[(2R)-2-methoxy-3-(4- octadecylcarbamoyloxy) piperidinocarbonyloxypropyloxy]carbonyl] aminomethyl-pyridinium chloride, in several experimentally induced shock models.
    Nagaoka J, Harada K, Kimura A, Kobayashi S, Murakami M, Yoshimura T, Yamada K, Asano O, Katayama K, Yamatsu I.
    Arzneimittelforschung; 1991 Jul 15; 41(7):719-24. PubMed ID: 1663352
    [Abstract] [Full Text] [Related]

  • 9. Biological effects of the new platelet-activating factor receptor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride.
    Imanishi N, Murakami-Uchida M, Koike H, Natsume Y, Morooka S.
    Arzneimittelforschung; 1994 Mar 15; 44(3):317-22. PubMed ID: 8192697
    [Abstract] [Full Text] [Related]

  • 10. Biochemical and pharmacological characterization of L-659,989: an extremely potent, selective and competitive receptor antagonist of platelet-activating factor.
    Hwang SB, Lam MH, Alberts AW, Bugianesi RL, Chabala JC, Ponpipom MM.
    J Pharmacol Exp Ther; 1988 Aug 15; 246(2):534-41. PubMed ID: 2841449
    [Abstract] [Full Text] [Related]

  • 11. [PAF-antagonists with phospholipid structure. 2. Phospholipids with heteroarene head groups and variations of the phosphorus-nitrogen distance; synthesis, characterization and structure-activity relationships].
    Kertscher HP, Ostermann G.
    Pharmazie; 1991 Oct 15; 46(10):708-11. PubMed ID: 1803385
    [Abstract] [Full Text] [Related]

  • 12. Biological effect of orally active platelet-activating factor receptor antagonist SM-10661.
    Komuro Y, Imanishi N, Uchida M, Morooka S.
    Mol Pharmacol; 1990 Sep 15; 38(3):378-84. PubMed ID: 2402227
    [Abstract] [Full Text] [Related]

  • 13. Effects of synthetic analogues of platelet-activating factor (PAF) on fibrinolytic activity in the rat.
    Hofmann B, Meisgeier U, Kertscher P, Ostermann G.
    Biomed Biochim Acta; 1988 Sep 15; 47(10-11):S161-4. PubMed ID: 3150268
    [Abstract] [Full Text] [Related]

  • 14. Natural 1-O-alkylglycerols reduce platelet-activating factor-induced release of [3H]-serotonin in rabbit platelets.
    Pédrono F, Cheminade C, Legrand AB.
    Prostaglandins Leukot Essent Fatty Acids; 2004 Jul 15; 71(1):19-23. PubMed ID: 15172680
    [Abstract] [Full Text] [Related]

  • 15. Antagonism of platelet activating factor receptor binding and stimulated phosphoinositide-specific phospholipase C in rabbit platelets.
    Morrison WJ, Shukla SD.
    J Pharmacol Exp Ther; 1989 Sep 15; 250(3):831-5. PubMed ID: 2550620
    [Abstract] [Full Text] [Related]

  • 16. PAF receptor. 2. Quantitative hydrophobic contribution of the agonist's etheroxid chain.
    Heymans F, Steiner E, Jouquey S, Godfroid JJ.
    J Lipid Mediat; 1989 Sep 15; 1(5):303-12. PubMed ID: 2562436
    [Abstract] [Full Text] [Related]

  • 17. High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation.
    Tahraoui L, Floch A, Mondot S, Cavero I.
    Mol Pharmacol; 1988 Aug 15; 34(2):145-51. PubMed ID: 2842653
    [Abstract] [Full Text] [Related]

  • 18. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.
    Ring PC, Seldon PM, Barnes PJ, Giembycz MA.
    Mol Pharmacol; 1993 Feb 15; 43(2):302-12. PubMed ID: 8381515
    [Abstract] [Full Text] [Related]

  • 19. Effect of platelet agonists on the binding of platelet-activating factor to human platelets.
    Burgers JA, Akkerman JW.
    J Lipid Mediat; 1992 Sep 15; 5(3):289-300. PubMed ID: 1334723
    [Abstract] [Full Text] [Related]

  • 20. Rabbit blastocysts accumulate platelet-activating factor (PAF) and lyso-PAF in vitro.
    Jones MA, Kudolo GB, Harper MJ.
    Mol Reprod Dev; 1992 Jul 15; 32(3):243-50. PubMed ID: 1323306
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.